Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19
Figure 10.Forest plot of the meta-analysis of age-based differences in safety in LPV/r therapy in patients with COVID-19.